Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)
The National Cancer Institute (NCI) is inviting applications for R21 grants aimed at high-risk, high-reward research in cancer immunology. The goal is to explore new ideas or technologies that could enhance our understanding of immune responses, tumor-immune interactions, and immune networks related to cancer. These projects should be innovative and different from typical R01 projects, with th…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Peer Reviewed Cancer, Idea Award
Dept. of the Army -- USAMRAA
-
DoW, Ovarian Cancer, Pilot Award
Dept. of the Army -- USAMRAA
-
DoD Rare Cancers, Concept Award
Dept. of the Army -- USAMRAA
-
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health ▸ National Cancer Institute
-
DoW Rare Cancers Concept Award
Defense Health Agency Contracting Activity - DHACA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers